EGCG reduces C-X-C motif chemokine ligands (CXCL10) and myxovirus resistance protein 1 staining intensity in epidermis equivalents and CXCL10 secretion by keratinocytes upon stimulation, demonstrating potential for local treatment of lichen planus [135]. The gene discussed is CXCL10; the disease is lichen planus.